Harry Kovelman Sells 15,488 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Harry Kovelman sold 15,488 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $1.27, for a total transaction of $19,669.76. Following the completion of the transaction, the insider directly owned 90,245 shares in the company, valued at approximately $114,611.15. The trade was a 14.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Harry Kovelman also recently made the following trade(s):

• On Thursday, August 20th, Harry Kovelman sold 17,250 shares of Myomo stock. The shares were sold at an average price of $1.73, for a total transaction of $29,842.50.

Myomo Stock Performance

MYO stock opened at $1.24 on Wednesday. Myomo, Inc. has a twelve month low of $0.60 and a twelve month high of $1.89. The company has a quick ratio of 2.01, a current ratio of 2.31 and a debt-to-equity ratio of 1.98. The company has a market cap of $49.12 million, a P/E ratio of -3.65 and a beta of 1.50. The business’s fifty day moving average is $1.29 and its 200-day moving average is $1.05.

Myomo (NYSEAMERICAN:MYO) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.01. Myomo had a negative return on equity of 138.85% and a negative net margin of 33.53%.The business had revenue of $11.70 million during the quarter, compared to the consensus estimate of $10.35 million. Equities research analysts forecast that Myomo, Inc. will post -0.32 EPS for the current year.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets boosted their price objective on shares of Myomo from $9.50 to $10.00 and gave the company a “buy” rating in a report on Monday, June 8th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $10.00.

Institutional Trading of Myomo

A hedge fund recently bought a new stake in Myomo stock. Jefferies Financial Group Inc. purchased a new stake in Myomo, Inc. (NYSEAMERICAN:MYO) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 704,275 shares of the company’s stock, valued at approximately $641,000. Jefferies Financial Group Inc. owned approximately 1.83% of Myomo as of its most recent filing with the Securities and Exchange Commission (SEC). 44.99% of the stock is owned by institutional investors.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.